Put a face to a name – this session is the perfect opportunity to get face-to-face time with key opinion leaders, leading biotech and pharmaceutical companies, and innovative researchers in obesity drug development. Establish meaningful connections with companies working on earlystage through to clinical stage weight loss therapies. Build upon these connections throughout the rest of the conference and gain individual insight beyond the papers and press releases into the pioneering research and therapeutic development